In a nutshell This article reviewed the types and frequency of different skin-related side effects that patients with melanoma experience while receiving biological treatments. Some background Treatment for patients with melanoma has changed in recent years from chemotherapy to biological therapies. Biological therapies include BRAF inhibitors...
Read MoreSide effects of immunotherapy vs chemotherapy for the treatment of melanoma
In a nutshell This study wanted to compare the side effects of immunotherapy and those of chemotherapy for melanoma. The study found that immunotherapy was associated with fewer side effects than treatment with chemotherapy. Some background Standard treatment for cancer included chemotherapies. These include drugs that attack and kill cancer...
Read MoreSide effects of immunotherapy vs chemotherapy for the treatment of lung cancer
In a nutshell This study wanted to compare the side effects of immunotherapy and those of chemotherapy for lung cancer. The study found that immunotherapy was associated with fewer side effects than treatment with chemotherapy. Some background Standard treatment for cancer included chemotherapies. These include drugs that attack and kill cancer cells....
Read MoreWhat factors predict blood-related side effects of tyrosine kinase inhibitors in chronic myeloid leukemia?
In a nutshell This study aimed to investigate the occurrence of hematological (blood-related) side effects in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. This study concluded that bone marrow fibrosis at diagnosis was a predictor of hematological side effects from tyrosine...
Read MoreEvaluating the risk of lung side effects in older patients with Hodgkin lymphoma
In a nutshell This study investigated whether older patients with Hodgkin lymphoma (HL) were at high risk for developing lung side effects when treated with bleomycin (Blenoxane). The authors found that the odds of developing lung side effects increased significantly with age in these patients. Some background For patients with HL, age is one of...
Read MoreEvaluating immune-related side effects associated with pembrolizumab.
In a nutshell This study wanted to find out what put patients at risk of having immune-related side effects when they were treated with pembrolizumab (Keytruda). The study found that patients with a higher body mass index (BMI; a measurement of weight in relation to height) and more cycles of treatment were more likely to determine immune-related side...
Read MoreEvaluating immune-related side effects associated with pembrolizumab.
In a nutshell This study wanted to find out what put patients at risk of having immune-related side effects when they were treated with pembrolizumab (Keytruda). The study found that patients with a higher body mass index (BMI; a measurement of weight in relation to height) and more cycles of treatment were more likely to determine immune-related side...
Read MoreEvaluating immune-related side effects associated with pembrolizumab.
In a nutshell This study wanted to find out what put patients at risk of having immune-related side effects when they were treated with pembrolizumab (Keytruda). The study found that patients with a higher body mass index (BMI; a measurement of weight in relation to height) and more cycles of treatment were more likely to determine...
Read MoreEvaluating immune-related side effects associated with pembrolizumab.
In a nutshell This study wanted to find out what put patients at risk of having immune-related side effects when they were treated with pembrolizumab (Keytruda). The study found that patients with a higher body mass index (BMI; a measurement of weight in relation to height) and more cycles of treatment were more likely to determine immune-related side...
Read MoreIs radiotherapy after chemotherapy associated with late side effects in patients with Hodgkin’s lymphoma?
In a nutshell This study evaluated the long-term outcomes of chemotherapy plus radiotherapy for patients with early-stage classical Hodgkin's lymphoma (cHL). The authors found that this treatment combination was highly effective, with minimal late side effects. Some background Early-stage (stage 1 to 2) cHL is usually treated with a...
Read MoreHeart-related side effects associated with ibrutinib treatment
In a nutshell The study aimed to identify cardiovascular (heart and blood vessel) adverse drug reactions (CV-ADR) associated with ibrutinib treatment. This study concluded that severe and sometimes fatal cardiac events occur in patients exposed to ibrutinib. Some background Ibrutinib (Imbruvica) is a targeted therapy that can be used for...
Read MoreHeart-related side effects associated with ibrutinib treatment
In a nutshell The study aimed to identify cardiovascular (heart and blood vessel) adverse drug reactions (CV-ADR) associated with ibrutinib treatment. This study concluded that severe and sometimes fatal cardiac events occur in patients exposed to ibrutinib. Some background Ibrutinib (Imbruvica) is a targeted therapy that can be used for...
Read More
